Bromodomain Containing 7 (BRD7) Peptide
BRD7
Reactivity: Human
Host: Synthetic
BP, IHC, WB
-
- Target See all BRD7 products
- BRD7 (Bromodomain Containing 7 (BRD7))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-BRD7 antibody (Catalog #: ARP39018_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- BRD7 (Bromodomain Containing 7 (BRD7))
- Background
-
BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.
Alias Symbols: BP75, CELTIX1, NAG4
Protein Interaction Partner: AGR2,BARD1,BHLHE40,BRD3,BTBD2,DVL1,FTH1,HAP1,HIST1H2AL,HIST2H2BE,HIST2H3A,HIST2H4A,HIST3H3,HNRNPUL1,LAMA4,NEFL,PAFAH1B3,PSMD11,PTPN13,RIF1,RPLP1,SERPINB9,AGR2,BHLHE40,BRCA1,BTBD2,FTH1,HNRNPUL1,IRF2,LAMA4,MYC,PAFAH1B3,POU2F1,PSMD11,RPLP1,SERPINB9
Protein Size: 651 - Molecular Weight
- 74 kDa
- Gene ID
- 29117
- NCBI Accession
- NM_013263, NP_037395
- UniProt
- Q9NPI1
-
You are here:
